Biblio Discovery — Demo Discovery Service

12 hasil untuk "Angela L. Ferguson"

Menampilkan 1–12 · 0,19 detik · RSS

  1. Artikel Jurnal

    Late-stage MC38 tumours recapitulate features of human colorectal cancer – implications for appropriate timepoint selection in preclinical studies

    Nicholas J. Shields; Estelle M. Peyroux; Angela L. Ferguson dkk.

    Frontiers in Immunology, Vol. 14 · 2023 · Inggris · DOAJ Scopus

    Anti-tumour T cell responses play a crucial role in controlling the progression of colorectal cancer (CRC), making this disease a promising candidate for immunotherapy. However, responses to immune-targeted therapies are currently limited to subpopulations of patients and specific types of cancer…

  2. Artikel Jurnal

    Approaches to spatially resolving the tumour immune microenvironment of hepatocellular carcinoma

    Felix Marsh-Wakefield; Angela L Ferguson; Ken Liu dkk.

    Therapeutic Advances in Medical Oncology, Vol. 14 · 2022 · Inggris · DOAJ Scopus

    Hepatocellular carcinoma (HCC) is a common and deadly cancer worldwide. Many factors contribute to mortality and place an individual at high risk of developing HCC, including viral infection, alcohol intake, metabolic-associated disease, autoimmunity and genetic liver disorders. Although there are…

  3. Artikel Jurnal

    Exposure to solar ultraviolet radiation establishes a novel immune suppressive lipidome in skin-draining lymph nodes

    Benita C. Y. Tse; Angela L. Ferguson; Yen Chin Koay dkk.

    Frontiers in Immunology, Vol. 13 · 2023 · Inggris · DOAJ Scopus

    The ability of ultraviolet radiation to suppress the immune system is thought to be central to both its beneficial (protection from autoimmunity) and detrimental (carcinogenic) effects. Previous work revealed a key role for lipids particularly platelet-activating factor and sphingosine-1-phosphate…

  4. Artikel Jurnal Teks lengkap

    A randomised pilot trial of perioperative propranolol combined with celecoxib versus standard of care in stage III melanoma: The ProCel study protocol

    Katina J. Selvaraj; Diona L. Damian; J. Guy Lyons dkk.

    PLOS One, Vol. 21 No. 1 · 2026 · Inggris · PLOS Scopus

    In cutaneous melanoma patients, the presence of lymph node or in transit metastasis can be associated with poor survival. Adjuvant treatment with BRAF-MEK inhibitors or immunotherapy is costly and can cause side effects, so there remains a need for safe and inexpensive adjuvant treatments…

    Juga tersedia di: DOAJ, DOAJ

  5. Artikel Jurnal

    Understanding the Cancer-Associated Fibroblast (CAF) and Its Biomarker Fibroblast Activation Protein (FAP), and Aspects in Human Liver Cancer

    Yiqun Amy Qu; JiaLi C. Huang; Ziqi V. Wang dkk.

    Frontiers in Bioscience-Landmark, Vol. 30 No. 12 · 2025 · Inggris · DOAJ Scopus

    Tumours contain many fibroblasts, endothelial cells, and leukocytes that are emerging as therapeutic targets complementary to targeting genetically unstable cancer cells. Immunotherapies directed towards this tumour microenvironment (TME) are increasingly effective. Targeting the endothelium has…

  6. Artikel Jurnal

    Detailed spatial immunophenotyping of primary melanomas reveals immune cell subpopulations associated with patient outcome

    Grace H. Attrill; Hansol Lee; Annie T. Tasker dkk.

    Frontiers in Immunology, Vol. 13 · 2022 · Inggris · DOAJ Scopus

    While the tumor immune microenvironment (TIME) of metastatic melanoma has been well characterized, the primary melanoma TIME is comparatively poorly understood. Additionally, although the association of tumor-infiltrating lymphocytes with primary melanoma patient outcome has been known for decades…

  7. Artikel Jurnal

    Distinct pretreatment innate immune landscape and posttreatment T cell responses underlie immunotherapy-induced colitis

    Kazi J. Nahar; Felix Marsh-Wakefield; Robert V. Rawson dkk.

    JCI Insight, Vol. 7 No. 21 · 2022 · Inggris · DOAJ Scopus

    Immune-related adverse events represent a major hurdle to the success of immunotherapy. The immunological mechanisms underlying their development and relation to antitumor responses are poorly understood. By examining both systemic and tissue-specific immune changes induced by combination…

  8. Artikel Jurnal

    A unique cytotoxic CD4+ T cell‐signature defines critical COVID‐19

    Sarah Baird; Caroline L Ashley; Felix Marsh‐Wakefield dkk.

    Clinical & Translational Immunology, Vol. 12 No. 8 · 2023 · Inggris · DOAJ Scopus

    Abstract Objectives SARS‐CoV‐2 infection causes a spectrum of clinical disease presentation, ranging from asymptomatic to fatal. While neutralising antibody (NAb) responses correlate with protection against symptomatic and severe infection, the contribution of the T‐cell response to disease…

  9. Artikel Jurnal

    A single dose, BCG-adjuvanted COVID-19 vaccine provides sterilising immunity against SARS-CoV-2 infection

    Claudio Counoupas; Matt D. Johansen; Alberto O. Stella dkk.

    npj Vaccines, Vol. 6 No. 1 · 2021 · Inggris · DOAJ Scopus

    Abstract Global control of COVID-19 requires broadly accessible vaccines that are effective against SARS-CoV-2 variants. In this report, we exploit the immunostimulatory properties of bacille Calmette-Guérin (BCG), the existing tuberculosis vaccine, to deliver a vaccination regimen with potent…